Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing
Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs
Quantum Genomics (Euronext Growth: ALQGC, OTCQX: QNNTF), a biopharmaceutical company specializing in the development
Quantum Genomics publishes its results for fiscal 2021
and gives an update on its activity
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the
Update of Shareholding Situation Following April 27, 2022 Capital Raise
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a
Quantum Genomics announces successful capital raising with a gross sum of approximately €15.6 M€ Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat